PubMed Health⌕ Search
Home/Archive/PubMed

PubMed · 10105065

AIDS update.

K Darr
View original source ↗Export metadata ↓

Abstract

AIDS continues to be a major health threat. Yet, life style changes and use of preventive measures have proved effective in dramatically slowing the spread of HIV in at least one group. Society's challenge is to find ways to make these benefits available to others--IV drug users, minority populations, and a new group, college students--both for humane reasons and because society must protect itself from deadly communicable diseases. Hospitals must find ways to provide efficacious, episodic treatment for acute phases of the illness and to assist organizations providing alternative sources of care. Financing this care will remain problematic for all providers. Caring for PWAs while protecting staff remains a major ethical and legal challenge and one in which managers must play a significant role.

Explore related subjects

Acquired Immunodeficiency SyndromeDisease OutbreaksHospitalsHumansUnited StatesJournal Article

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

K Darr. 1990. AIDS update.. https://doi.org/10.1080/00185868.1990.9948422

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

PubMed2001

Methods for estimating the AIDS incubation time distribution when date of seroconversion is censored.

In most cohort studies on HIV infection and AIDS, data on time from seroconversion to AIDS or death are doubly censored, both at the time origin and at the endpoint of interest. In epidemiological research, the most frequently adopted approach is to restrict the analysis to persons with narrow seroconversion intervals and to impute the midpoint of this interval as date of seroconversion. For many cohort studies, the consequence is that a substantial proportion of the data is not used. We consider four methods that are expected to be less biased when all cohort data are used: two imputation methods, conditional mean and multiple imputation, and two likelihood maximization methods. We derive the likelihood structure of the cohort data and clarify its dependence on study design. All methods are applied to data from the Amsterdam cohort study among injection drug users. In a simulation study the data generation process of this cohort study is imitated. The performance of midpoint, conditional mean and multiple imputation are compared. With midpoint imputation, both an analysis using the full data set, as well as one restricted to the cases with small seroconversion intervals, is performed. Conditional mean imputation comes out as the preferred method. It gives best results with respect to mean squared error. Moreover, when confidence intervals are computed through standard methods that ignore the uncertainty in the imputed date of seroconversion, coverage probabilities are almost correct.

Acquired Immunodeficiency Syndrome↗
PubMed2001

Efficiency comparisons of rank and permutation tests based on summary statistics computed from repeated measures data.

A popular method of using repeated measures data to compare treatment groups in a clinical trial is to summarize each individual's outcomes with a scalar summary statistic, and then to perform a two-group comparison of the resulting statistics using a rank or permutation test. Many different types of summary statistics are used in practice, including discrete and continuous functions of the underlying repeated measures data. When the repeated measures processes of the comparison groups differ by a location shift at each time point, the asymptotic relative efficiency of (continuous) summary statistics that are linear functions of the repeated measures has been determined and used to compare tests in this class. However, little is known about the non-null behaviour of discrete summary statistics, about continuous summary statistics when the groups differ in more complex ways than location shifts or where the summary statistics are not linear functions of the repeated measures. Indeed, even simple distributional structures on the repeated measures variables can lead to complex differences between the distribution of common summary statistics of the comparison groups. The presence of left censoring of the repeated measures, which can arise when these are laboratory markers with lower limits of detection, further complicates the distribution of, and hence the ability to compare, summary statistics. This paper uses recent theoretical results for the non-null behaviour of rank and permutation tests to examine the asymptotic relative efficiencies of several popular summary statistics, both discrete and continuous, under a variety of common settings. We assume a flexible linear growth curve model to describe the repeated measures responses and focus on the types of settings that commonly arise in HIV/AIDS and other diseases.

Acquired Immunodeficiency Syndrome↗